KYPHON HV-R Bone CementRecalls & reported problems across all models
Medtronic Sofamor Danek, Inc. · 2 models in the FDA device registry
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 61
- Deaths reported
- 0
- Injuries reported
- 23
- Recalls
- 0
We found 2 models of KYPHON HV-R Bone Cement by Medtronic Sofamor Danek, Inc. in the FDA's device registry (GUDID). Together they are named in 61 adverse event reports in the FDA's MAUDE database, received between Apr 17, 2017 and Mar 3, 2026 — classified as 23 injuries, 38 malfunctions.
The most frequently reported specific device problem is “Leak/Splash” (19 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works
Reports received per month, all models
Most reported KYPHON HV-R Bone Cement problems
Device problems
- Leak/Splash19
- Adverse Event Without Identified Device or Use Problem16
- Coagulation in Device or Device Ingredient8
- Migration7
- Appropriate Device Problem Term/Code Not Available5
- Migration or Expulsion of Device4
- Chemical Problem2
- Fluid/Blood Leak1
Patient problems
- No Known Impact Or Consequence To Patient24
- Extravasation10
- Pain8
- No Clinical Signs, Symptoms or Conditions7
- Inadequate Pain Relief6
- No Code Available2
- No Consequences Or Impact To Patient2
- Bone Fracture(s)1
KYPHON HV-R Bone Cement models
2 models, most reported first. Each model has its own page with its reports, recalls and device details.
- KYPHON® HV-R® Bone Cement C01ACEMENT, BONE, VERTEBROPLASTY57 reports
- KYPHON® HV-R® Bone Cement C01ACEMENT, BONE, VERTEBROPLASTY4 reports
Recent KYPHON HV-R Bone Cement adverse event reports
The 15 most recent reports across all models, in the reporter's own words as published by the FDA.
MalfunctionMar 3, 2026Coagulation in Device or Device Ingredient
INFORMATION WAS RECEIVED FROM HEALTHCARE PROVIDER (HCP) VIA A MANUFACTURER REPRESENTATIVE REGARDING A PATIENT HAVING SPINAL THERAPY FOR VERTEBRAL COMPRESSION FRACTURE OF LUMBAR LEVEL 3 AND LUMBAR 4. IT WAS REPORTED THAT THE CEMENT HARDENED PREMATURELY IN THE VERTEBRAL BODY AT L3, PREVENTING REMOVAL OF THE CURETTE AND WORKING CANNULA. THE CURETTE AND WORKING CANNULA WERE PROTRUDING FROM THE STAB INCISION AT L3. BOLT CUTTERS AND A HIGH SPEED DRILL WERE REQUIRED TO REMOVE THE PROTRUDING METAL COMPONENTS. PART OF THE CURETTE AND WORKING CANNULA REMAINED WITHIN THE PATIENT'S BONE. A SMALL INCISION WAS MADE AT THE LEVEL OF THE LEFT L3 PEDICLE TO FACILITATE REMOVAL OF THE EXPOSED MATERIAL. THERE WERE NO PATIENT SYMPTOMS OR COMPLICATIONS WERE REPORTEDAS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24492901 ↗MalfunctionFeb 11, 2026Coagulation in Device or Device Ingredient
INFORMATION WAS RECEIVED FROM HEALTHCARE PROVIDER (HCP) VIA A MANUFACTURER REPRESENTATIVE REGARDING A PATIENT HAVING VERTEBROPLASTY PROCEDURE FOR AN OSTEOPOROTIC CONDITION ON THE SACRUM. IT WAS REPORTED THAT THE FIRST BOX OF CEMENT WAS MIXED FOR 1 MINUTE AND INJECTED AT 5.5-6 MINUTES, BUT THE CEMENT HAD ALREADY HARDENED, RESULTING IN NO CEMENT BEING INJECTED. THE SECOND BOX WAS MIXED FOR 45 SECONDS AND INJECTED AT THE 3.5-MINUTE MARK; SMALL AMOUNTS OF CEMENT WERE ABLE TO BE INJECTED BEFORE THE CEMENT HARDENED. COMPUTED TOMOGRAPHY WAS USED TO CHECK CEMENT PLACEMENT AND THE AMOUNT INJECTED, REVEALING SMALL AMOUNTS OF CEMENT AT THE POSTERIOR BORDER OF THE SACRUM SURROUNDING THE WORKING PORT. THE PROCEDURE WAS COMPLETED SUCCESSFULLY WITH THE ORIGINAL PRODUCT. NO PATIENT SYMPTOMS/COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT. ADDITIONAL INFORMATION WAS RECEIVED THAT THE PROCEDURE THAT WAS INVOLVED WAS BILATERAL SACROPLASTY. THE THIRD BOX OF CEMENT IS THE SAME BATCH AS THE PREVIOUS ONE, THIS IS BATCH WHERE MOST CEMENT ARE INJECTED INTO THE PATIENT BODY. THE MIXING PROCESS AND INSERTION PROCESS IS MUCH EARLIER THAN THE PREVIOUS ONES. THE MIXING TIME WAS 30 SECONDS AND WAS INJ
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24311230 ↗MalfunctionFeb 11, 2026Coagulation in Device or Device Ingredient
INFORMATION WAS RECEIVED FROM HEALTHCARE PROVIDER (HCP) VIA A MANUFACTURER REPRESENTATIVE REGARDING A PATIENT HAVING VERTEBROPLASTY PROCEDURE FOR AN OSTEOPOROTIC CONDITION ON THE SACRUM. IT WAS REPORTED THAT THE FIRST BOX OF CEMENT WAS MIXED FOR 1 MINUTE AND INJECTED AT 5.5-6 MINUTES, BUT THE CEMENT HAD ALREADY HARDENED, RESULTING IN NO CEMENT BEING INJECTED. THE SECOND BOX WAS MIXED FOR 45 SECONDS AND INJECTED AT THE 3.5-MINUTE MARK; SMALL AMOUNTS OF CEMENT WERE ABLE TO BE INJECTED BEFORE THE CEMENT HARDENED. COMPUTED TOMOGRAPHY WAS USED TO CHECK CEMENT PLACEMENT AND THE AMOUNT INJECTED, REVEALING SMALL AMOUNTS OF CEMENT AT THE POSTERIOR BORDER OF THE SACRUM SURROUNDING THE WORKING PORT. THE PROCEDURE WAS COMPLETED SUCCESSFULLY WITH THE ORIGINAL PRODUCT. NO PATIENT SYMPTOMS/COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT. ADDITIONAL INFORMATION WAS RECEIVED THAT THE PROCEDURE THAT WAS INVOLVED WAS BILATERAL SACROPLASTY. THE THIRD BOX OF CEMENT IS THE SAME BATCH AS THE PREVIOUS ONE, THIS IS BATCH WHERE MOST CEMENT ARE INJECTED INTO THE PATIENT BODY. THE MIXING PROCESS AND INSERTION PROCESS IS MUCH EARLIER THAN THE PREVIOUS ONES. THE MIXING TIME WAS 30 SECONDS AND WAS INJ
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24311229 ↗MalfunctionFeb 11, 2026Coagulation in Device or Device Ingredient
INFORMATION WAS RECEIVED FROM HEALTHCARE PROVIDER (HCP) VIA A MANUFACTURER REPRESENTATIVE REGARDING A PATIENT HAVING VERTEBROPLASTY PROCEDURE FOR AN OSTEOPOROTIC CONDITION ON THE SACRUM. IT WAS REPORTED THAT THE FIRST BOX OF CEMENT WAS MIXED FOR 1 MINUTE AND INJECTED AT 5.5-6 MINUTES, BUT THE CEMENT HAD ALREADY HARDENED, RESULTING IN NO CEMENT BEING INJECTED. THE SECOND BOX WAS MIXED FOR 45 SECONDS AND INJECTED AT THE 3.5-MINUTE MARK; SMALL AMOUNTS OF CEMENT WERE ABLE TO BE INJECTED BEFORE THE CEMENT HARDENED. COMPUTED TOMOGRAPHY WAS USED TO CHECK CEMENT PLACEMENT AND THE AMOUNT INJECTED, REVEALING SMALL AMOUNTS OF CEMENT AT THE POSTERIOR BORDER OF THE SACRUM SURROUNDING THE WORKING PORT. THE PROCEDURE WAS COMPLETED SUCCESSFULLY WITH THE ORIGINAL PRODUCT. NO PATIENT SYMPTOMS/COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT. ADDITIONAL INFORMATION WAS RECEIVED THAT THE PROCEDURE THAT WAS INVOLVED WAS BILATERAL SACROPLASTY. THE THIRD BOX OF CEMENT IS THE SAME BATCH AS THE PREVIOUS ONE, THIS IS BATCH WHERE MOST CEMENT ARE INJECTED INTO THE PATIENT BODY. THE MIXING PROCESS AND INSERTION PROCESS IS MUCH EARLIER THAN THE PREVIOUS ONES. THE MIXING TIME WAS 30 SECONDS AND WAS INJ
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24311211 ↗MalfunctionJun 9, 2025Leak/Splash; Leak/Splash
INFORMATION WAS RECEIVED FROM HEALTHCARE PROVIDER (HCP) VIA A MANUFACTURER REPRESENTATIVE REGARDING A PATIENT HAVING CEMENT INJECTION AT TH12 FOR PRIMARY OSTEOPOROSIS- COMPRESSION FRACTURE. IT WAS REPORTED THAT THERE WAS CEMENT OUTFLOW FROM THE SIDE OF THE VERTEBRAL BODY TO THE VEIN. THERE WERE NO PATIENT SYMPTOMS REPORTED. THERE WERE NO FURTHER COMPLICATIONS REPORTED REGARDING THE EVENT
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22164846 ↗MalfunctionMay 14, 2025Coagulation in Device or Device Ingredient; Coagulation in Device or Device Ingredient
INFORMATION WAS RECEIVED FROM USER FACILITY VIA A MANUFACTURER REPRESENTATIVE REGARDING A DEVICE USED FOR SPINAL THERAPY. IT WAS REP ORTED THAT THE CEMENT THE MIXTURE TURNED HARD OR DRY, TO SUCH AN EXTENT THAT IT COULD NOT BE STIRRED. THERE WAS NO PATIENT INVOLVEMENT REPORTED. THERE WERE NO FURTHER COMPLICATIONS REPORTED REGARDING THE EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22016929 ↗MalfunctionNov 28, 2022Coagulation in Device or Device Ingredient; Leak/Splash; Coagulation in Device or Device Ingredient; Leak/Splash
INFORMATION WAS RECEIVED FROM HEALTHCARE PROVIDER (HCP) VIA A MANUFACTURER REPRESENTATIVE REGARDING AN EVENT WHICH OCCURRED DURING AN UNKNOWN SPINAL PROCEDURE IN A PATIENT DIAGNOSED WITH COMPRESSION FRACTURE DUE TO PRIMARY OSTEOPOROSIS. IT WAS REPORTED THAT AFTER CEMENT WAS FILLED INTO THE VERTEBRAL BODY, THE BFD IN THE PROCESS OF FILLING WAS PLACED IN THE VERTEBRAL BODY, CAUSING THE CEMENT TO LEAK FROM THE VERTEBRAL BODY INTO THE BFD, LEAK FROM THE VERTEBRAL ARCH ROOT, AND HARDEN. IT IS UNKNOWN WHEN THE CEMENT HARDENED BUT THE ISSUE WAS NOTICED WHEN THE BFD WAS REMOVED AFTER THE HARDENING TIME WAS COMPLETED. THERE WAS NO PATIENT SYMPTOM REPORTED. THERE WERE NO FURTHER COMPLICATIONS REPORTED REGARDING THE EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15867591 ↗InjuryJul 5, 2022Leak/Splash; Leak/Splash
INFORMATION WAS RECEIVED FROM HEALTHCARE PROVIDER (HCP) VIA A MANUFACTURER REPRESENTATIVE REGARDING A PATIENT HAVING PERCUTANEOUS VE RTEBROPLASTY FOR PRIMARY OSTEOPOROSIS. TYPE OF FRACTURE: COMPRESSION FRACTURE IT WAS REPORTED THAT THE CEMENT LEAKED INTO THE BLOOD VESSEL. THERE WAS NO EXTRAVASATION. THE PRODUCT WAS USED SUCCESSFULLY. THE CEMENT HAD BEEN STORED AT AN APPROPRIATE TEMPERATURE BEFORE AND DURING THE PROCEDURE. THERE WAS NO PATIENT SYMPTOM REPORTED. THERE WERE NO FURTHER COMPLICATIONS REPORTED REGARDING THE EVENT. ADDITIONAL INFORMATION WAS RECEIVED: LEVEL IMPLANTED: 3RD LUMBAR VERTEBRA THE CEMENT THAT LEAKED INTO THE BLOOD VESSEL. CEMENT FLOWED FROM THE VEINS IN FRONT OF THE VERTEBRAL BODY TO LUNG. THE VENOUS CEMENT HAS BEEN REMOVED WITH A CATHETER. IT COULD BE REMOVED WITHOUT ANY PROBLEMS. THERE WAS AN EXTENSION OF HOSPITALIZATION. THE EXTENSION OF HOSPITALIZATION WAS FOR FOLLOW-UP DUE TO THE CEMENT LEAKAGE.
Patient problems: Extravasation
MAUDE report 14912640 ↗MalfunctionJul 3, 2022Leak/Splash; Leak/Splash
INFORMATION WAS RECEIVED FROM A HEALTHCARE PROVIDER (HCP) VIA MANUFACTURER REPRESENTATIVE REGARDING A PATIENT WHO UNDERWENT PERCUTAN EOUS VERTEBROPLASTY FOR L4 COMPRESSION FRACTURE SPINAL THERAPY FOR PRIMARY OSTEOPOROSIS. IT WAS REPORTED THAT THE CEMENT LEAKED TO THE RIGHT-SIDE REGION OF THE VERTEBRAL BODY. NO FURTHER COMPLICATIONS OR SYMPTOMS WERE REPORTED. ADDITIONAL INFORMATION WAS RECEIVED VIA MANUFACTURER REPRESENTATIVE THAT THERE HAS NOT BEEN PLANNED ANY ADDITIONAL TREATMENT OR SURGERY FOR THE REMOVAL OF IMPLANT.
Patient problems: Extravasation
MAUDE report 14902796 ↗InjuryDec 30, 2021Leak/Splash; Leak/Splash
INFORMATION WAS RECEIVED FROM HEALTHCARE PROFESSIONAL VIA FIELD REPRESENTATIVE REGARDING PATIENT WITH PRE-OP DIAGNOSIS POSSIBLE SCREW MIGRATION INVOLVED IN THE REPORTED EVENT. LEVELS IMPLANTED T10; T11. IT WAS REPORTED THAT INTRA-OPERATIVELY, FENESTRATED SCREWS WITH CEMENT. INJECTED CEMENT DOWNSIZES 3 BONE FILLERS AND WATCHED ON XRAY. CEMENT EXTRAVASATED TO SPINAL CANAL. DUE TO EXTRAVASATION IN SPINAL CANAL THE DURAL TEAR WAS REPORTED. ADDITIONAL SURGERY- LAMINECTOMY DONE AND DURAL REPAIR WAS PERFORMED AS A RESULT OF THIS EVENT. THERE WAS DELAY IN OVERALL PROCEDURE TIME. THERE WAS NO MALFUNCTION OF THE CDS SYSTEM DURING USE. CEMENT STORED AT PROPER TEMPERATURE(S) BEFORE AND DURING THE PROCEDURE. CEMENT MIXED FOR 60 SECONDS. PROCEDURE WAS COMPLETED SUCCESSFULLY WITH ORIGINAL PRODUCTS. ON (B)(6) 2021, RECEIVED ADDITIONAL INFORMATION THAT THERAPY WAS CEMENTING SCREWS. UNKNOWN FORMER SCREWS. ADDED 2 HOURS TO CASE. LEVELS CEMENT EXTRAVASATED T11 AND T12. CEMENT EXTRAVASATED AT IMPLANTED LEVEL AND ONE LEVEL BELOW. ADDITIONAL SURGERY/TREATMENT-LAMINECTOMY AND DURAL REPAIR WAS PERFORMED ON THE SAME DAY.
Patient problems: Extravasation; Spinal Cord Injury
MAUDE report 13116447 ↗MalfunctionMar 23, 2020Leak/Splash; Leak/Splash
IT WAS REPORTED VIA CLINICAL STUDY THAT THE PATIENT UNDERWENT KYPHOPLASTY AT L4. INTRA-OP, CEMENT EXTRAVASATION OCCURRED IN THE PARA SPINAL TISSUES. THIS CEMENT EXTRAVASATION WAS FOUND NOT TO BE GREATER THAN 15 MM; AND THE EVENT WAS DETERMINED NOT TO BE CLINICALLY SIGNIFICANT.
Patient problems: Extravasation
MAUDE report 9868981 ↗MalfunctionFeb 26, 2020Migration; Migration
THE CEMENT HAD BEEN MIXED PROPERLY AND HAD BEEN FILLED IN A UNIFORM SOFTNESS WITHOUT ANY VISCOSITY PROBLEMS. THERE HAD BEEN NO MIGRATION SINCE THE MIGRATION THAT OCCURRED INITIALLY. CURRENTLY, NO COMPLICATIONS HAVE OCCURRED.
Patient problems: Extravasation
MAUDE report 9757576 ↗MalfunctionJan 18, 2020Migration; Migration
IT WAS REPORTED THAT THE PATIENT PRESENTED WITH COMPRESSION FRACTURE AT T12; AND UNDERWENT BALLOON KYPHOPLASTY. INTRA-OP, WHEN THE BALLOON WAS INFLATED TO 4CC, THE BALLOON INTERFERED WITH THE ENDPLATE. THERE WAS NO MALFUNCTION WITH THE BALLOON. WHEN THE CEMENT WAS FILLED TO 3.5CC, THE CEMENT LEAKED TO THE LEFT SIDE; HOWEVER, THE PROCEDURE WAS COMPLETED SUCCESSFULLY WITH THE SAME PRODUCT. NO PATIENT COMPLICATIONS WERE REPORTED DUE TO THIS EVENT.
Patient problems: Extravasation
MAUDE report 9604697 ↗MalfunctionJan 2, 2020Migration; Migration
IT WAS REPORTED THAT THE PATIENT UNDERWENT BALLOON KYPHOPLASTY DUE TO PRIMARY OSTEOPOROSIS. INTRA-OPERATIVELY, DURING THE OPERATION THE CEMENT CAME INTO THE VEIN ON THE SIDE OF THE VERTEBRAL BODY. AFTER THAT, THE CEMENT SOLIDIFIED. IT WAS CONFIRMED THAT THE CEMENT WHICH CAME INTO THE VEIN ALSO SOLIDIFIED. THE FOLLOWING DAY, IT WAS CHECKED WHEN TAKING CT THAT THE CEMENT WAS NOT ON THE SIDE OF THE VERTEBRAL BODY BUT CAME TO THE LUNGS, AND HAS TURNED TO PULMONARY EMBOLISM. BUT THERE WERE NO SYMPTOMS. THERE WAS NO DELAY IN OVERALL PROCEDURE TIME AS A RESULT OF THIS EVENT. THERE WERE NO PATIENT COMPLICATIONS AS THE RESULT OF THIS EVENT.
Patient problems: Pulmonary Embolism
MAUDE report 9537591 ↗MalfunctionDec 6, 2019Migration; Migration
IT WAS REPORTED VIA CLINICAL STUDY THAT THE PATIENT UNDERWENT CEMENTOPLASTY. INTRA-OP, CEMENT EXTRAVASATION WAS FOUND AT THE SUPERIOR DISC SPACE AND INFERIOR DISC SPACE. THIS CEMENT EXTRAVASATION WAS FOUND NOT BE EXTRUDED BY MORE THAN 15 MM; AND HENCE, WAS DETERMINED NOT TO BE CLINICALLY SIGNIFICANT.
Patient problems: Extravasation
MAUDE report 9424555 ↗
Other Medtronic Sofamor Danek, Inc. products
- CD HORIZON Spinal System342 models · 2,323 reports
- GRAFTONand GRAFTON PLUSDemineralized Bone Matrix (DBM)25 models · 12 reports · 14 recalls
- METRx System5 models · 672 reports
- INFUSE Bone Graft6 models · 576 reports · 1 recall
- CD HORIZON SOLERA VOYAGER Spinal System60 models · 411 reports
- POWEREASE Instruments8 models · 331 reports · 1 recall
- Catalyft PL Expandable Interbody System16 models · 279 reports · 1 recall
- INFINITY Occipitocervical Upper Thoracic System35 models · 63 reports · 5 recalls
Sources and updates
- Models: FDA GUDID, file dated Oct 13, 2026. Models are grouped by the brand name the manufacturer registered.
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page